Literature DB >> 10570315

BALB/c mice produce blister-causing antibodies upon immunization with a recombinant human desmoglein 3.

J L Fan1, O Memar, D J McCormick, B S Prabhakar.   

Abstract

Pemphigus vulgaris (PV) is an Ab-mediated autoimmune blistering disease of mucotaneous surfaces. Over 95% of the patients with PV express DR4 or DRw6, and the disease is characterized by the presence of autoantibodies directed against desmoglein 3 (Dsg 3), a protein expressed on keratinocytes. An appropriate animal model is required to understand immunoregulation and to address the role of immunogenetic components in the production of pathogenic Abs that are characteristic of PV. Therefore, we turned to the development of a mouse model. Four strains of female mice (BALB/c, DBA/1, SJL/J, and HRS/J) were screened for their ability to produce pathogenic anti-Dsg 3 Abs. We demonstrated that only BALB/c mice immunized with a full-length Dsg 3 can produce pathogenic Abs capable of causing acantholysis of human foreskin in culture and blistering in neonatal mice. This observation suggested that either H-2d or the BALB background contains the immunogenetic makeup necessary for the production of pathogenic anti-Dsg 3 Abs. No correlation was noted between a given isotype and the pathogenic potential of autoantibodies from different strains of mice. Similarly, the pattern of reactivity of Abs with a panel of 46 synthetic peptides that span the entire Dsg 3 failed to reveal any association between binding specificity and the pathogenic potential, and suggested that pathogenic Abs might recognize conformational epitopes. Moreover, our studies showed that the epitopes recognized by pathogenic Abs are contained within the extracellular Dsg 3.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10570315

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

Review 1.  Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches.

Authors:  Robert Pollmann; Thomas Schmidt; Rüdiger Eming; Michael Hertl
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

2.  Antigen-specific B cell depletion for precision therapy of mucosal pemphigus vulgaris.

Authors:  Jinmin Lee; Daniel K Lundgren; Xuming Mao; Silvio Manfredo-Vieira; Selene Nunez-Cruz; Erik F Williams; Charles-Antoine Assenmacher; Enrico Radaelli; Sangwook Oh; Baomei Wang; Christoph T Ellebrecht; Joseph A Fraietta; Michael C Milone; Aimee S Payne
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

3.  Relevance of differential immunogenicity of human and mouse recombinant desmoglein-3 for the induction of acantholytic autoantibodies in mice.

Authors:  S Kaithamana; J-L Fan; O Memar; K Li; J Uitto; G S Seetharamaiah; B S Prabhakar
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.